Dolacga/Ga-68 Dolacga Injection
Category: Analytical/Test
Developers: National Atomic Research Institute (NARI)
Product Description:Ga-68 Dolacga Injection is the first glycopeptide-based PET radiotracer targeting ASGPR on hepatocytes, with a fast, robust Ga-68 radiolabel and consistent manufacturing. Its lyophilized kit enables room-temperature storage, global distribution, and on-demand, on-site preparation, providing clinically actionable, high-contrast, quantitative PET images of liver function that outperform current assessment tools. Ga-68 Dolacga is the subject of a study that will assess treatment response and liver function changes in patients of early-stage liver cancer receiving radiofrequency ablation.
Developers: National Atomic Research Institute (NARI)
Product Description:Ga-68 Dolacga Injection is the first glycopeptide-based PET radiotracer targeting ASGPR on hepatocytes, with a fast, robust Ga-68 radiolabel and consistent manufacturing. Its lyophilized kit enables room-temperature storage, global distribution, and on-demand, on-site preparation, providing clinically actionable, high-contrast, quantitative PET images of liver function that outperform current assessment tools. Ga-68 Dolacga is the subject of a study that will assess treatment response and liver function changes in patients of early-stage liver cancer receiving radiofrequency ablation.
